HLTHAGE 1AA3 Lecture 14: Lecture 14 – Big Pharma
26 Mar 2017
School
Department
Course
Professor
Document Summary
Until 2000, big pharma does not pay attention to sub-saharan africa and the hiv issue there. Their excuse: africa did not have the infrastructure via which the pharmaceutical companies could work. Aids (cid:272)o(cid:374)fere(cid:374)(cid:272)e i(cid:374) outh afri(cid:272)a (cid:374)otes big phar(cid:373)a"s i(cid:374)tra(cid:374)sige(cid:374)(cid:272)e. Big pharma speaks to patent protection and intellectual property rights. Glaxo wellcome first to blink and reduces its price of aids drug for south africa from. . 50 to . 00 (800% mark up if sold at cost) Drug companies have surpassed all other 500 fortune companies in profit rates (rated first or second in the list of most profitable for more than 30 of the last 40 years) Big pharma always keeps science r&d separate from marketing. Pharma-policy unit: top floor of corporate affairs (executives) + legal department + strategic planners worked on ever increasing profits. Doctors evaluated commercial aspects of r&d and regulatory reporting requirements. If a drug cures the incurable but does not sell: great science but lousy business.
